Estrogen receptor immunoreactivity within subregions of the rat forebrain: Neuronal distribution and association with perikarya containing choline acetyltransferase

Brain Research

Volumn 849, Issue 1-2, 1999, Pages 253-274

  Mufson, Elliott J ^a   Cai, Wei Jun ^a   Jaffar, Syed ^a   Chen, Er Yun ^a   Stebbins, Glenn ^a   Sendera, Timothy ^a   Kordower, Jeffrey H ^a  

^a Research Center for Brain Repair   (United States)

Author keywords

Alzheimer's disease; Basal forebrain; Cholinergic; Gonadal; Ovariectomy; Steroids

Indexed keywords

CHOLINE ACETYLTRANSFERASE; ESTROGEN; ESTROGEN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; FOREBRAIN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; OVARIECTOMY; PERIKARYON; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLINE O-ACETYLTRANSFERASE; ESTROGEN RECEPTOR ALPHA; FEMALE; IMMUNOHISTOCHEMISTRY; NEURONS; ORGAN SPECIFICITY; OVARIECTOMY; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN;

EID: 0032750506     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01960-5     Document Type: Article

References (72)

1. Alves S.E., Weiland N.G., Hayashi S., McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J. Comp. Neurol. 391:1998;322-334.
2. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol. (Berl.). 61:1983;101-108.
3. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-414.
4. Benzing W.C., Kordower J.H., Mufson E.J. Galanin immunoreactivity within the primate basal forebrain: evolutionary change between monkeys and apes. J. Comp. Neurol. 336:1993;31-39.
5. Bevitt D.J., Milton I.D., Piggot N., Henry L., Carter M.J., Toms G.L., Lennard T.W., Westley B., Angus B., Horne C.H. New monoclonal antibodies to oestrogen and progesterone receptors effective for paraffin section immunohistochemistry. J. Pathol. 183:1997;228-232.
6. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., Davis K.L. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64:1995;749-760.
7. Blaustein J.D., Brown T.J. Progesterone decreases the concentration of hypothalamic and anterior pituitary estrogen receptors in ovariectomized rats. Brain Res. 304:1984;225-236.
8. Blaustein J.D., Turcotte J.C. Estrogen receptor-immunostaining of neuronal cytoplasmic processes as well as cell nuclei in guinea pig brain. Brain Res. 495:1989;75-82.
9. Blaustein J.D. Cytoplasmic estrogen receptors in rat brain: immunocytochemical evidence using three antibodies with distinct epitopes. Endocrinology. 131:1992;1336-1342.
10. Blaustein J.D., Lehman M.N., Turcotte J.C., Greene G. Estrogen receptors in dendrites and axon terminals in the guinea pig hypothalamus. Endocrinology. 131:1992;281-290.
11. Blaustein J.D. Estrogen receptor immunoreactivity in rat brain: rapid effects of estradiol injection. Endocrinology. 132:1993;1218-1224.
12. Blurton-Jones M.M., Roberts J.A., Tuszynski M.H. Estrogen receptor immunoreactivity in the adult primate brain: neuronal distribution and association with p75, TrkA, and choline acetyltransferase. J. Comp. Neurol. 405:1999;529-542.
13. Coggeshall R.E., Lekan H.A. Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J. Comp. Neurol. 364(1):1996;6-15. published erratum appears in J. Comp. Neurol. 369 (1) (1996) 162.
14. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
15. Gibbs R.B., Pfaff D.W. Effects of estrogen and fimbria/fornix transection on p75NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp. Neurol. 116:1992;23-39.
16. Gibbs R.B. Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann. N.Y. Acad. Sci. 743:1994;165-196.
17. Gibbs R.B. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res. 720:1996;61-68.
18. Gibbs R.B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151:1998;289-302.
19. Guillery R.W., Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J. Comp. Neurol. 386:1997;2-7.
20. Hefti F., Hartikka J., Knusel B. Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases. Neurobiol. Aging. 10:1989;515-533.
21. Kahl U.A., Mufson E.J. Coexpression of the estrogen alpha receptor and galanin immunoreactivity in the rat central nervous system: effect of ovariectomy. Soc. Neurosci. Abst. 24:1998;1473.
22. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 48:1997;1517-1521.
23. Kordower J.H., Mufson E.J. Galanin-like immunoreactivity within the primate basal forebrain: differential staining patterns between humans and monkeys. J. Comp. Neurol. 294:1990;281-292.
24. Kordower J.H., Le H.K., Mufson E.J. Galanin immunoreactivity in the primate central nervous system. J. Comp. Neurol. 319:1992;479-500.
25. Kordower J.H., Chen E.Y., Sladek J.R.J., Mufson E.J. trk-immunoreactivity in the monkey central nervous system: forebrain. J. Comp. Neurol. 349:1994;20-35.
26. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5925-5930.
27. LaFlamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (Eralpha and Erbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtye. J. Neurobiol. 36:1998;357-378.
28. Levey A.I., Bolam J.P., Rye D.B., Hallanger A.E., Demuth R.M., Mesulam M.M., Wainer B.H. A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidineand and benzidine dihydrochloride. J. Histochem. Cytochem. 34:1986;1449-1457.
29. Liposits Z., Kallo I., Coen C.W., Paull W.K., Flerko B. Ultrastructural analysis of estrogen receptor immunoreactive neurons in te medial preoptic area of the female rat brain. Histochemistry. 93:1990;233-239.
30. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp.Neurol. 89:1985;484-490.
31. MacLusky N.J., McEwen B.S. Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites. Endocrinology. 106:1980;192-202.
32. Marcharmont B., Su J.L., Parikh I. Monoclonal antibodies against estrogen receptor: interaction with different molecular forms and functions of the receptor. Biochem. 21:1982;6916-6921.
33. Marchamont B., Anderson W.L., Rosenberg B., Parikh I. Interaction of estrogen receptors of calf uterus with a monoclonal antibody: probing of various molecular forms. Biochemistry. 3:1984;3907-3912.
34. McEwen B.S., Alves S.E., Bulloch K., Weiland N.G. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 48:1997;S8-15.
35. McMillan P.J., Singer C.A., Dorsa D.M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J. Neurosci. 16:1996;1860-1865.
36. Mesulam M.M., Mufson E.J., Wainer B.H., Levey A.I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
37. Mufson E.J., Bothwell M., Hersh L.B., Kordower J.H. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons. J. Comp. Neurol. 285:1989;196-217.
38. Mufson E.J., Li J.M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport. 8:1996;25-29.
39. Mufson E.J., Lavine N., Jaffar S., Kordower J.H., Quirion R., Saragovi H.U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
40. Mufson E.J., Jaffar S., Levey A.I. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. J. Comp. Neurol. 392:1998;313-329.
41. E.J. Mufson, W. Cai, T. Sendera, J.H. Kordower, Estrogen alpha receptor expression within cholinergic neurons of the mammalian basal forebrain: effect of ovariectomy and species differences, Steriods Meet Growth Factors, Ulm, Germany, 1999.
42. O'Malley B. The steriod receptor superfamily: more excitement predicted for the future. Mol. Endocrynol. 4:1990;363-369.
43. Paganini-Hill A., Henderson V.W. Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156:1996;2213-2217.
44. G. Paxinos, C. Watson, The rat brain in stereotaxic corrdinates, 4 ed., Academic Press, London, 1998.
45. Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British J. Med. 57:1978;1457-1459.
46. Perry R.H., Candy J.M., Perry E.K., Irving D., Blessed G., Fairbairn A.F., Tomlinson B.E. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33:1982;311-315.
47. Robbins T.W., Everitt B.J., Marston H.M., Wilkinson J., Jones G.H., Page K.J. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res. 35:1989;221-240.
48. Rosene D.L., Roy N.J., Davis B.J. A cryoprotection method that facilitates cutting frozen sections of whole monkey brains for histological and histochemical processing without freezing artifact. J. Histochem. Cytochem. 34:1986;1301-1315.
49. Rouse S.T., Levey A.I. Expression of m1-m4 muscarinic acetylcholine receptor immunoreactivity in septohippocampal neurons and other identified hippocampal afferents. J. Comp. Neurol. 375:1996;406-416.
50. Rye D.B., Mesulam M.-M., Mufson E.J., Saper C.B., Wainer B.H. Cortical projections arising form the basal forebrain: a study of cholinergic versus non-cholinergic components employing combined retrograde tracing and immunohistochemical localizations of choline acetyltransferase. Neurosci. 13:1984;627-644.
51. Schneider L.S., Farlow M.R., Henderson V.W., Pogoda J.M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
52. Shughrue P.J., Bushnell C.D., Dorsa D.M. Estrogen receptor messenger ribonucleic acid in female rat brain during the estrous cycle: a comparison with ovariectomized females and intact males. Endocrinology. 131:1992;381-388.
53. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids. 61:1996;678-681.
54. Shughrue P.J., Lane M.V., Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol. 388:1997;507-525.
55. Shughrue P.J., Scrimo P., Lane M., Askew R., Merchenthaler I. The distribution of estrogen receptor-beta mRNA in forebrain regions of the estrogen receptor-alpha knockout mouse. Endocrinology. 138:1997;5649-5652.
56. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294:1990;76-95.
57. Simerly R.B., Young B.J. Regulation of estrogen receptor messenger ribonucleic acid in rat hypothalamus by sex steroid hormones. Mol. Endocrinol. 5:1991;424-432.
58. Simerly R.B., Carr A.M., Zee M.C., Lorang D. Ovarian steroid regulation of estrogen and progesterone receptor messenger ribonucleic acid in the anteroventral periventricular nucleus of the rat. J. Neuroendocrinol. 8:1996;45-56.
59. Singh M., Meyer E.M., Millard W.J., Simpkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
60. Skipper J.K., Young L.J., Bergeron J.M., Tetzlaff M.T., Osborn C.T., Crews D. Identification of an isoform of the estrogen receptor messenger RNA lacking exon four and present in the brain. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7172-7175.
61. Sobreviela T., Clary D.O., Reichardt L.F., Brandabur M.M., Kordower J.H., Mufson E.J. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350:1994;587-611.
62. Sobreviela T.S., Jaffar S., Mufson E.J. TrkA, galanin and nitric oxide synthase within basal forebrain neurons in the rat. Neurosci. 87:1998;447-461.
63. Sohrabji F., Greene L.A., Miranda R.C., Toran-Allerand C.D. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC12 cells. J. Neurobiol. 25:1994;974-988.
64. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J. Neurosci. 14:1994;459-471.
65. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11110-11114.
66. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432. see comments.
67. Toran-Allerand C.D., Miranda R.C., Bentham W.D., Sohrabji F., Brown T.J., Hochberg R.B., MacLusky N.J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. U.S.A. 89:1992;4668-4672.
68. Wenk G.L., Stoehr J.D., Quintana G., Mobley S., Wiley R.G. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 10:1994;5986-5995.
69. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:1981;122-126.
70. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57:1982;407-417.
71. Zhou Y., Shuhrue P.J., Dorsa D.M. Estrogen receptor protein is differentially regulated in the preoptic area of the brain and in the uterus during the rat estrous cycle. Neuroendocrin. 61:1995;276-283.
72. Miller M.M., Hyder S.M., Assayag R., Panarella S.R., Tousignant P., Franklin K.B. Estrogen modulates spontaneous alteration and the cholinergic phenotype in the basal forebrain. Neurosci. 91:1999;1143-1153.